12:00 AM
 | 
Oct 18, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Avonex: Marketed

Wayne State University researchers presented data from a 156-patient non-randomized, non-blinded study comparing Avonex, Berlex Laboratories Inc.'s Betaseron interferon beta-1b and

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >